| AKT proto-oncogene overexpression is an early event during sporadic colon carcinogenesis. | colorectal, |
| AKT2, a putative oncogene encoding a member of a subfamily of protein-serine/threonine kinases, is amplified in human ovarian carcinomas. | ovarian, |
| Plakophilin 3 oncogene as prognostic marker and therapeutic target for lung cancer. | lung, |
| [The expression of oncogene AKT2 in laryngeal squamous cell carcinoma and its clinical significance]. | laryngeal, |
| Akt2 and nucleophosmin/B23 function as an oncogenic unit in human lung cancer cells. | lung, |
| Data suggest that Akt2/B23 functions as an oncogenic unit to drive tumorigenesis of A549 lung cancer cells. | lung, |
| Molecular cloning of the akt oncogene and its human homologues AKT1 and AKT2: amplification of AKT1 in a primary human gastric adenocarcinoma. | gastric, |
| Constitutively activated thymoma viral proto-oncogene 2 (Akt2) caused ras-related C3 botulinum toxin substrate 1 (Rac1) activation. | thymoma, |
| Molecular alterations of the AKT2 oncogene in ovarian and breast carcinomas. | breast,ovarian, |
| Amplification and overexpression of the AKT2 oncogene in a subset of human pancreatic ductal adenocarcinomas. | pancreatic, |
| Identification of a chromosome 3p14.3-21.1 gene, APPL, encoding an adaptor molecule that interacts with the oncoprotein-serine/threonine kinase AKT2. | None |
| Oncogenic transformation induced by membrane-targeted Akt2 and Akt3. | None |
| stimulates growth by phosphorylating the tuberous sclerosis complex 2 (Tsc2) tumour suppressor and inhibiting formation of a Tsc1-Tsc2 complex | None |
| Cloning, chromosomal localization and expression analysis of the mouse Akt2 oncogene. | None |
| Transforming activity and mitosis-related expression of the AKT2 oncogene: evidence suggesting a link between cell cycle regulation and oncogenesis. | None |